BetterLife FSHD: A Patient-driven Health and Research Platform

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1+
SponsorFSHD Society

About this trial

BetterLife FSHD is a registry platform built to support people living with FSHD. It connects patients with personalized resources, tools, and research opportunities that match their health experiences and needs. At the same time, BetterLife collects secure health and experience data from patients to support research. This data is shared with researchers to help better understand FSHD and work toward improved care, treatments, and outcomes for the community.

Learn more and enroll at: www.BetterLifeFSHD.org

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Individuals with a clinical or genetic diagnosis of FSHD, or individuals with a family history of FSHD who are showing symptoms

Age 1 year or older

Residing in the United States or its territories

If age 18 or older, individual must be able and willing to provide consent

Disqualifiers

Individuals residing outside the United States or its territories

Unable or unwilling to provide consent, or assent, when applicable

Trial population

People with FSHD living in the United States or its territories age one year or older.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Observational

    Other intervention

    Observational study

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Longitudinal Health Data

Survey questions to capture information on demographics, health history, FSHD diagnosis (clinical diagnosis, genetic testing, family history, etc.), and FSHD symptom management (e.g., use of assistive devices, ventilation, surgery).

Time frame
Assessed annually from enrollment until study completion (10 years)
2

Self Reported FSHD Progression

Survey questions that cover muscle weakness, symptom onset, and key progression milestones, and which can be used to estimate FSHD Clinical Score (FCS) . A higher score indicates more disease severity.

Time frame
Assessed every 6 months, until study completion (10 years)

Secondary outcomes

1

Anxiety Patient Reported Outcome Measure

Assesses frequency and impact of anxiety symptoms using a 5-point rating system. Higher scores indicate more anxiety.

Time frame
Quarterly, until study completion (10 years)
2

Depression Patient Reported Outcome Measure

Assesses frequency and impact of depression symptoms using a 5-point rating system. Higher scores indicate more depression.

Time frame
Quarterly, until study completion (10 years)
3

Pain Patient Reported Outcome Measure

Assesses the quality of pain and interference with daily life using a 5-point rating system. Higher scores indicate higher levels of pain and interference.

Time frame
Quarterly, until study completion (10 years)
4

Sleep Patient Reported Outcome Measure

Assesses the quality of sleep using a 5-point rating system. Higher scores indicate poor sleep quality.

Time frame
Quarterly, until study completion (10 years)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.